Microtek Medical Holdings, Inc - Post-Effective Amendment to an S-8 filing (S-8 POS)
09 Noviembre 2007 - 1:58PM
Edgar (US Regulatory)
AS
FILED
WITH THE SECURITIES AND EXCHANGE COMMISSION ON NOVEMBER 9, 2007.
REGISTRATION
NO. 333-117736
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
POST-EFFECTIVE
AMENDMENT NO. 1
TO
FORM S-8
REGISTRATION
STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
Microtek
Medical Holdings, Inc.
(Exact
name of Registrant as specified in its charter)
|
Georgia
|
58-1746149
|
|
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
|
incorporation
or organization)
|
Identification
Number)
|
13000
Deerfield Parkway, Suite 300
Alpharetta,
Georgia 30004
(Address
of principal executive offices, including zip code)
1999
Long-Term Incentive Plan, As Amended
(Full
title of the plan)
Dan
R. Lee
13000
Deerfield Parkway
Suite
300
Alpharetta,
Georgia 30004
(678)
896-4400
(Name,
address and telephone number of agent for service)
Copies
to:
Stephen
D. Fox, Esq.
Arnall
Golden Gregory LLP
171
17
TH
Street
Suite
2100
Atlanta,
Georgia 30363-1031
DEREGISTRATION
OF UNSOLD SECURITIES
This
Post-Effective Amendment No. 1 amends the Registration Statement on Form S-8,
Registration No. 333-117736 (the "Registration Statement"), of Microtek Medical
Holdings, Inc. (the "Company"), which was filed with the Securities and Exchange
Commission and became effective on July 29, 2004. The Registration
Statement registered 2,145,000 shares of the Company's common stock, par value
$0.001 per share ("Common Stock"), for sale pursuant to the 1999 Long-Term
Incentive Plan, as amended.
The
offering pursuant to the Registration Statement has been terminated. In
accordance with an undertaking made by the Company in the Registration Statement
to remove from registration, by means of a post-effective amendment, any of
the
securities which remain unsold at the termination of the offering, the Company
hereby removes from registration the 537,900 shares of Common Stock registered,
but unsold, under the Registration Statement.
PART
II
SIGNATURES
Pursuant
to the requirements of the Securities Act of 1933, the registrant certifies
that
it has reasonable grounds to believe that it meets all of the requirements
for
filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1
to
its Registration Statement on Form S-8 to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Atlanta, State of
Georgia, on the 9th day of November, 2007.
|
|
MICROTEK
MEDICAL HOLDINGS, INC.
|
|
|
|
|
|
|
|
|
By: /s/
Dan R. Lee
|
|
|
Name: Dan
R. Lee
|
|
|
Title: Chairman,
President and Chief Executive
Officer
|
Pursuant
to the requirements of the Securities Act of 1933, as amended, this
Post-Effective Amendment No. 1 to the Registration Statement has been signed
below by the following persons in the capacities indicated on the 9th day
of
November, 2007.
|
Signature
|
|
Title
|
|
|
|
|
|
/s/
Dan R.
Lee
|
|
Chairman,
President and Chief Executive Officer
|
|
Dan
R. Lee
|
|
(Principal
Executive Officer)
|
|
|
|
|
|
/s/
Roger G.
Wilson*
|
|
Chief
Financial Officer and Treasurer
|
|
Roger
G. Wilson
|
|
(Principal,
Financial and Accounting Officer)
|
|
|
|
|
|
/s/
Kenneth F.
Davis*
|
|
Director
|
|
Kenneth
F. Davis
|
|
|
|
|
|
|
|
/s/
Michael E. Glasscock,
III*
|
|
Director
|
|
Michael
E. Glasscock, III
|
|
|
|
|
|
|
|
/s/
Rosdon
Hendrix*
|
|
Director
|
|
Rosdon
Hendrix
|
|
|
|
|
|
|
|
/s/
Gene R.
McGrevin*
|
|
Director
|
|
Gene
R. McGrevin
|
|
|
|
|
|
|
|
/s/
Marc R.
Sarni*
|
|
Director
|
|
Marc
R. Sarni
|
|
|
|
|
|
|
|
/s/
Ronald L.
Smorada*
|
|
Director
|
|
Ronald
L. Smorada
|
|
|
|
|
|
|
|
By: /s/
Dan R.
Lee
|
|
|
|
Dan
R. Lee, as attorney-in-fact
|
|
|
Microtek Medical (NASDAQ:MTMD)
Gráfica de Acción Histórica
De Ene 2025 a Feb 2025
Microtek Medical (NASDAQ:MTMD)
Gráfica de Acción Histórica
De Feb 2024 a Feb 2025
